Oxygen Reserve Index in Airway Surgery in Children

April 20, 2023 updated by: Jin-Tae Kim, Seoul National University Hospital

A Randomized Controlled Trial of the Effect of Oxygen Reserve Index Monitoring for Preventing Hypoxia in Pediatric Airway Surgery

This study aimed to identify the effect of oxygen reserve index monitoring on the occurrence of oxygen desaturation (<90%) in pediatric patients undergoing airway surgery.

Study Overview

Status

Completed

Intervention / Treatment

Study Type

Interventional

Enrollment (Actual)

88

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

1 month to 18 years (Child, Adult)

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • pediatric patients receiving airway surgery

Exclusion Criteria:

  • baseline oxygen saturation less than 95%
  • patients diagnosed as respiratory distress syndrome, bronchopulmonary dysplasia, pneumonia requiring oxygen supplements

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Prevention
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Quadruple

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: ORI monitoring
SpO2, ECG, NIBP, and oxygen reserve index monitoring
Oxygen reserve index monitoring during the surgery
No Intervention: Standard monitoring
SpO2, ECG, NIBP monitoring

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Hypoxemia
Time Frame: from induction of anesthesia to end of operation, about 3 hours
Oxygen desaturation <= 90%
from induction of anesthesia to end of operation, about 3 hours

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Hypoxemia duration
Time Frame: from induction of anesthesia to end of operation, about 3 hours
Total length of time patient experienced hypoxemia during hypoxemic event (oxygen desaturation <= 90%)
from induction of anesthesia to end of operation, about 3 hours
Incidence and duration of severe hypoxemia
Time Frame: from induction of anesthesia to end of operation, about 3 hours
incidence and duration of oxygen desaturation <=85%
from induction of anesthesia to end of operation, about 3 hours
Rescue oxygenation
Time Frame: from induction of anesthesia to end of operation, about 3 hours
the number of the surgical procedure is interrupted and the anesthetist attempts to improve oxygenation of the child.
from induction of anesthesia to end of operation, about 3 hours
Hemodynamic instability
Time Frame: from induction of anesthesia to end of operation, about 3 hours
occurrence of hypotension requiring treatment, bradycardia requiring treatment, cardiac arrest with or without return of spontaneous circulation at any time during procedure
from induction of anesthesia to end of operation, about 3 hours
unexpected pediatric intensive care admission
Time Frame: from induction of anesthesia to end of operation, about 3 hours
requirements of unexpected pediatric intensive care admission
from induction of anesthesia to end of operation, about 3 hours
unanticipated postoperative mechanical support
Time Frame: from induction of anesthesia to end of operation, about 3 hours
Requirement for unanticipated postoperative mechanical ventilation or any other form of non-invasive ventilation including high-flow nasal oxygen
from induction of anesthesia to end of operation, about 3 hours

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

January 18, 2022

Primary Completion (Actual)

March 30, 2023

Study Completion (Actual)

March 30, 2023

Study Registration Dates

First Submitted

January 18, 2022

First Submitted That Met QC Criteria

January 18, 2022

First Posted (Actual)

January 31, 2022

Study Record Updates

Last Update Posted (Actual)

April 24, 2023

Last Update Submitted That Met QC Criteria

April 20, 2023

Last Verified

April 1, 2023

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • 2112-055-1281

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

UNDECIDED

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Hypoxemia During Surgery

Clinical Trials on ORI monitoring

Subscribe